Hyperplastic changes within the leptomeninges of the rat and monkey in response to chronic intracerebroventricular infusion of nerve growth factor

Experimental Neurology

Volumn 145, Issue 1, 1997, Pages 24-37

  Day Lollini, Patricia A ^a   Stewart, Gregory R ^a   Taylor, Michael J ^b   Johnson, Randolph M ^a   Chellman, Gary J ^b  

^a Center for Biological Research   (United States)

^b ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL HYPERPLASIA; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LEPTOMENINX; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; RAT; RHOMBENCEPHALON; SPINAL CORD;

EID: 0031149479     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6448     Document Type: Article

References (52)

1. Aguayo A. J., Charron L., Bray G. M. Potential of Schwann cells from unmyelinated nerves to produce myelin: A quantitative ultrastructural and autoradiographic study. J. Neurocytol. 5:1976;565-573.
2. Anton E. S., Weskamp G., Reichardt L. F., Matthew W. D. Nerve growth factor and its low-affinity receptor promote Schwann cell migration. Proc. Natl. Acad. Sci. USA. 91:1994;2795-2799.
3. Bartus R. T., Dean III R. L., Beer B., Lippa A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
4. Bunge R. P., Bunge M. B., Eldridge C. F. Linkage between axonal ensheathment and basal lamina production by Schwann cells. Annu. Rev. Neurosci. 9:1986;305-328.
5. Davies P., Maloney A. J. F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 2:1976;1403.
6. Davies P. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res. 171:1979;319-327.
7. Dekker A. J., Langdon D. J., Gage F. H., Thal L. J. NGF increases cortical acetylcholine release in rats with lesions of the nucleus basalis. NeuroReport. 2:1991;577-580.
8. Dekker A. J., Winkler J., Ray J., Thal L. J., Gage F. H. Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basalis magnocellularis. Neuroscience. 60:1994;299-309.
9. Emmett C. J., Aswani S. P., Stewart G. R., Fairchild D., Johnson R. M. Dose-response comparison of recombinant human nerve growth factor and recombinant human basic fibroblast growth factor in the fimbria fornix model of acute cholinergic degeneration. Brain Res. 673:1995;199-207.
10. Good Laboratory Practice regulations for nonclinical laboratory studies. Code of Federal Regulations (CFR) (April 1). 1988;. p. 229-243.
11. Fischer W., Wictorin K., Bjorklund A., Williams L. R., Varon S., Gage F. H. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature. 329:1987;65-68.
12. Fischer W., Bjorklund A., Chen K., Gage F. H. NGF improves spatial memory in aged rodents as a function of age. J. Neurosci. 11:1991;1889-1906.
13. Friden P. M., Walus L. R., Watson P., Doctrow S. R., Kozarich J. W., Backman C., Bergman H., Hoffer B., Bloom F., Granholm A. C. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science. 259:1993;373-377.
14. Gage F. H., Armstrong D. M., Williams L. R., Varon S. Morphological response of axotomized septal neurons to nerve growth factor. J. Comp. Neurol. 269:1988;147-155.
15. Hardy J., Adolfsson R., Alafuzoff I., Bucht G., Marcusson J., Nyberg P., Perdahl E., Wester P., Winblad B. Transmitter deficits in Alzheimer's disease. Neurochem. Intl. 7:1985;545-563.
16. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transection. J. Neurosci. 14:1986;2155-2162.
17. Hefti F. Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 25:1994;1418-1435.
18. Isaacson L. G., Crutcher K. A. The duration of sprouted cerebrovascular axons following intracranial infusion of nerve growth factor. Exp. Neurol. 131:1995;174-179.
19. Isaacson L. G., Saffran B. N., Crutcher K. A. Intracerebral NGF infusion induces hyperinnervation of cerebral blood vessels. Neurobiol. Aging. 11:1990;51-55.
20. Isaacson L. G., Saffran B. N., Crutcher K. A. Nerve growth factor-induced sprouting of mature, uninjured sympathetic axons. J. Comp. Neuro. 326:1992;327-336.
21. Kawaja M. D., Rosenberg M. B., Yoshida K., Gage F. H. Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats. J. Neurosci. 12:1992;2849-2864.
22. Koliatsos V. E., Nauta H. J. W., Clatterbuck R. E., Holtzmann D. M., Mobley W. E. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. J. Neurosci. 10:1990;3801-3813.
23. Koliatsos V. E., Applegate M. D., Knüsel B., Junard E. O., Burton L. E., Mobley W. C., Hefti F. F., Price D. L. Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat. Exp. Neurol. 112:1991a;161-173.
24. Koliatsos V. E., Clatterbuck R. E., Nauta H. J. W., Knüsel B., Burton L. E., Hefti F. F., Mobley W. C., Price D. L. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann. Neurol. 30:1991b;831-840.
25. Kromer L. F. Nerve growth factor treatment after brain injury prevents neuronal death. Science. 235:1987;214-216.
26. E. L. Lehmann, 1975, Nonparametrics: Statistical methods based on ranks, 232, 238, Holden Day, San Francisco.
27. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 237:1987;1154-1162.
28. Mandel R. J., Gage F. H., Thal L. J. Spatial learning in rats: Correlation with cortical choline acetyltransferase and improvement with NGF following NBM damage. Exp. Neurol. 104:1989;208-217.
29. Menesini Chen M. G., Chen J. S., Levi-Montalcini R. Sympathetic nerve fibers ingrowth in the central nervous system of neonatal rodent upon intracerebral NGF injections. Arch. Ital. Biol. 116:1978;53-84.
30. Mirsky R. Definition of Major Cell Types in the CNS and PNS. 1982;Plenum Press. p. 144-151.
31. Guide for the care and use of laboratory animals. 1985;Public Health Service, Washington.
32. Olson L. Outgrowth of sympathetic adrenergic neurons in mice treated with a nerve-growth factor (NGF). Zeitschrift fur Zellforschung. 81:1967;155-173.
33. Ondris D., Billieu C., Schwenk K., Page S., Isaacson L. K. Nerve growth factor-induced plasticity of cerebrovascular innervation. Soc. Neurosci. 20:1994;1093.
34. Oppenheim R. W. The neurotrophic theory and naturally occurring motoneuron death. Trends Neurosci. 12:1989;252-255.
35. Pardridge W. M. Peptide Drug Delivery to the Brain. 1985;Raven Press, New York. p. 99-122.
36. Phelps C. H., Gage F. H., Growdon J. H., Hefti F., Harbaugh R., Johnston M. V., Khachaturian Z. S., Mobley W. C., Price D. L., Raskind M., Simpkins J., Thal L. J., Woodcock J. Commentary: Potential use of nerve growth factor to treat Alzheimer's disease. Neurobiol. Aging. 10:1989;205-207.
37. Rosenberg M. B., Friedmann T., Robertson R. C., Tuszynski M., Wolff J. A., Breakefield X. O., Gage F. H. Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression. Science. 242:1988;1575-1578.
38. Saffran B. N., Woo J. E., Mobley W. E., Crutcher K. A. Intraventricular NGF infusion in the mature rat brain enhances sympathetic innervation of cerebrovascular targets but fails to elicit sympathetic ingrowth. Brain Res. 492:1989;245-254.
39. Salzer J. L., Bunge R. P. Studies of Schwann cell proliferation. I. An analysis in tissue culture of proliferation during development, Wallerian degeneration and direct injury. J. Cell. Biol. 84:1980;739-752.
40. Salzer J. L., Williams A. K., Glazer L., Bunge R. P. Studies of Schwann cell proliferation. II. Characterization of the stimulation and specificity of the response to a neurite membrane fraction. J. Cell. Biol. 84:1980;753-766.
41. Squire L. Mechanisms of memory. Science. 232:1986;1612-1619.
42. Thoenen H., Barde Y. A. Physiology of nerve growth factor. Physiol. Rev. 60:1980;1284-1335.
43. Thoenen H., Bandtlow C., Heumann R. The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev. Physiol. Biochem. Pharmacol. 109:1987;145-178.
44. Tuszynski M. H., Sangu H., Amaral D. G., Gage F. H. Nerve growth factor infusion in primate brain reduces lesion-induced cholinergic neuronal degeneration. J. Neurosci. 10:1990;3604-3614.
45. Tuszynski M. H., Sangu H., Yoshida K., Gage F. H. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann. Neurol. 30:1991;625-636.
46. Vahlsing H. L., Varon S., Hagg T., Fass-Holmes B., Dekker A., Manley M., Manthorpe M. An improved device for continuous intraventricular infusions prevents the introduction of pump-derived toxins and increases the effectiveness of NGF treatments. Exp. Neurol. 105:1989;233-243.
47. Varon S. Glial cell markers. Adelman G. Encyclopedia of Neuroscience. 1987;462-463 Birkhäuser, Boston.
48. Whittemore S. R., Seiger A. The expression, localization and functional significance of beta-nerve growth factor in the central nervous system. Brain Res. Rev. 12:1987;439-464.
49. Williams L. R. Hypophagia is induced by intracerebroventricular administration of nerve growth factor. Exp. Neurol. 113:1991;31-37.
50. Williams L. R., Varon S., Peterson G. M., Wictorin K., Fischer W., Bjorklund A., Gage F. H. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria-fornix transection. Proc. Natl. Acad. Sci. USA. 83:1986;9231-9235.
51. Winkler J., Ramirez G. A., Kuhn H. G., Peterson D. A., Tuszynski M. H., Gage F. H., Thal L. J. Induction of Schwann cell hyperplasia in vivo after intracerebroventricular administration of nerve growth factor. Soc. Neurosci. 21:1995;278.
52. Wood P. M., Bunge R. P. Evidence that sensory axons are mitogenic for Schwann cells. Nature. 256:1975;662-664.